SEARCH
E-mail This Page   Text Size A A


Key Benefits for REQUIP XL[1-3]

REQUIP XL can improve symptom control in both
   early- and late-stage Parkinson's disease.
May be taken alone or in combination with L-dopa.
The only oral, once-a-day dopamine agonist medicine for
   Parkinson's disease.

Important Safety Information About REQUIP XL

REQUIP XL has been associated with sedating effects, including somnolence, and the possibility of falling asleep while engaged in activities of daily living, including operation of a motor vehicle. Syncope or symptomatic hypotension may occur more frequently during initial treatment or with an increase in dose. Increase in blood pressure and changes in heart rate may occur. Hallucinations may occur at any time during treatment. Impulse control symptoms, including pathological gambling and hypersexuality, have been reported in patients treated with dopaminergic agents, including ropinirole. REQUIP XL may potentiate the dopaminergic side effects of L-dopa and may cause and/or exacerbate pre-existing dyskinesia.